全文获取类型
收费全文 | 6599篇 |
免费 | 534篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 275篇 |
妇产科学 | 188篇 |
基础医学 | 855篇 |
口腔科学 | 125篇 |
临床医学 | 691篇 |
内科学 | 1524篇 |
皮肤病学 | 66篇 |
神经病学 | 507篇 |
特种医学 | 392篇 |
外国民族医学 | 1篇 |
外科学 | 958篇 |
综合类 | 95篇 |
一般理论 | 1篇 |
预防医学 | 491篇 |
眼科学 | 115篇 |
药学 | 331篇 |
中国医学 | 8篇 |
肿瘤学 | 500篇 |
出版年
2021年 | 74篇 |
2019年 | 70篇 |
2018年 | 103篇 |
2017年 | 74篇 |
2016年 | 87篇 |
2015年 | 122篇 |
2014年 | 125篇 |
2013年 | 189篇 |
2012年 | 279篇 |
2011年 | 264篇 |
2010年 | 189篇 |
2009年 | 178篇 |
2008年 | 252篇 |
2007年 | 251篇 |
2006年 | 264篇 |
2005年 | 292篇 |
2004年 | 251篇 |
2003年 | 203篇 |
2002年 | 228篇 |
2001年 | 222篇 |
2000年 | 184篇 |
1999年 | 180篇 |
1998年 | 116篇 |
1997年 | 97篇 |
1996年 | 108篇 |
1995年 | 97篇 |
1994年 | 95篇 |
1993年 | 73篇 |
1992年 | 180篇 |
1991年 | 177篇 |
1990年 | 137篇 |
1989年 | 162篇 |
1988年 | 168篇 |
1987年 | 167篇 |
1986年 | 129篇 |
1985年 | 138篇 |
1984年 | 104篇 |
1983年 | 74篇 |
1982年 | 60篇 |
1981年 | 50篇 |
1980年 | 47篇 |
1979年 | 68篇 |
1978年 | 60篇 |
1977年 | 48篇 |
1976年 | 62篇 |
1975年 | 55篇 |
1974年 | 59篇 |
1973年 | 47篇 |
1971年 | 41篇 |
1969年 | 41篇 |
排序方式: 共有7172条查询结果,搜索用时 15 毫秒
1.
2.
Fiene Marie Kuijper Uma V. Mahajan Seul Ku Daniel A.N. Barbosa Sheila M. Alessi Sherman C. Stein Kyle M. Kampman Brandon S. Bentzley Casey H. Halpern 《Neuromodulation》2022,25(2):253-262
ObjectivesCocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (CUD)-related deaths increased globally by 80% from 1990 to 2013. There is yet to be a regulatory-approved treatment. Emerging preclinical evidence indicates that deep brain stimulation (DBS) of the nucleus accumbens may be a therapeutic option. Prior to expanding the costly investigation of DBS for treatment of CUD, it is important to ensure societal cost-effectiveness.AimsWe conducted a threshold and cost-effectiveness analysis to determine the success rate at which DBS would be equivalent to contingency management (CM), recently identified as the most efficacious therapy for treatments of CUDs.Materials and MethodsQuality of life, efficacy, and safety parameters for CM were obtained from previous literature. Costs were calculated from a societal perspective. Our model predicted the utility benefit based on quality-adjusted life-years (QALYs) and incremental-cost-effectiveness ratio resulting from two treatments on a one-, two-, and five-year timeline.ResultsOn a one-year timeline, DBS would need to impart a success rate (ie, cocaine free) of 70% for it to yield the same utility benefit (0.492 QALYs per year) as CM. At no success rate would DBS be more cost-effective (incremental-cost-effectiveness ratio <$50,000) than CM during the first year. Nevertheless, as DBS costs are front loaded, DBS would need to achieve success rates of 74% and 51% for its cost-effectiveness to exceed that of CM over a two- and five-year period, respectively.ConclusionsWe find DBS would not be cost-effective in the short term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy. 相似文献
3.
4.
5.
6.
Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density. 总被引:1,自引:0,他引:1
David M Raffel Wei Chen Phillip S Sherman David L Gildersleeve Yong-Woon Jung 《Journal of nuclear medicine》2006,47(9):1490-1496
The norepinephrine analog (11)C-meta-hydroxyephedrine (HED) is used with PET to map the regional distribution of cardiac sympathetic neurons. HED is rapidly transported into sympathetic neurons by the norepinephrine transporter (NET) and stored in vesicles. Although much is known about the neuronal mechanisms of HED uptake and retention, there is little information about the functional relationship between HED retention and cardiac sympathetic nerve density. The goal of this study was to characterize the dependence of HED retention on nerve density in rats with graded levels of cardiac denervation induced chemically with the neurotoxin 6-hydroxydopamine (6-OHDA). METHODS: Thirty male Sprague-Dawley rats were divided into 6 groups, and each group was administered a different dose of 6-OHDA: 0 (controls), 7, 11, 15, 22, and 100 mg/kg intraperitoneally. One day after 6-OHDA injection, HED (3.7-8.3 MBq) was injected intravenously into each animal and HED concentrations in heart and blood at 30 min after injection were determined. Heart tissues were frozen and later processed by tissue homogenization and differential centrifugation into a membrane preparation for in vitro measurement of cardiac NET density. A saturation binding assay using (3)H-mazindol as the radioligand was used to measure NET density (maximum number of binding sites [B(max)], fmol/mg protein) for each heart. RESULTS: In control animals, NET B(max) was 388 +/- 23 fmol/mg protein and HED heart uptake (HU) at 30 min was 2.89% +/- 0.35 %ID/g (%ID/g is percentage injected dose per gram tissue). The highest 6-OHDA dose of 100 mg/kg caused severe cardiac denervation, decreasing both NET B(max) and HED HU to 8% of their control values. Comparing values for all doses of 6-OHDA, HED retention had a strong linear correlation with NET density: HU = 0.0077B(max) -0.028, r(2) = 0.95. CONCLUSION: HED retention is linearly dependent on NET density in rat hearts that have been chemically denervated with 6-OHDA, suggesting that HED retention is a good surrogate measure of NET density in the rat heart. This finding is discussed in relation to clinical observations of the dependence of HED retention on cardiac nerve density in human subjects using PET. 相似文献
7.
M Ardigo I Malizewsky ML Dell'Anna E Berardesca M Picardo 《Journal of the European Academy of Dermatology and Venereology》2007,21(10):1344-1350
BACKGROUND: Vitiligo is the most common pigmentary disorder with a global incidence from 0.1% to 2% in different geographical areas. Histopathology and histochemistry have shown the reduction of melanocytes in achromic patches, but microscopic changes of lesional and non-lesional skin are still not completely understood. Reflectance confocal microscopy (RCM), based on the different light reflectance index of cutaneous structures, allowed in vivo, en face microscopic evaluation of superficial skin layers with a resolution similar to skin histology. AIM: The purpose of this study was to evaluate RCM features of lesional and non-lesional skin of vitiligo patients. Moreover, re-pigmented areas were taken into consideration in order to evaluate melanocyte response to ultraviolet B (UVB) radiation. SUBJECTS AND METHODS: Sixteen patients of different phototypes affected by active non-segmental vitiligo and 10 controls were enrolled in the study. In vivo skin imaging was done using a commercially available RCM (Lucid, Vivascope 1500. Re-pigmented areas from 6 to 16 patients (after UVB narrow-band therapy) were also examined. RESULTS: Vitiligo lesions showed the disappearance of the bright rings normally seen at the dermo-epidermal junction. Moreover, non-lesional skin of vitiligo patients showed unexpected changes as the presence of half-rings or scalloped border-like features of the bright papillary rings. In re-pigmented areas after UVB narrow band therapy, the presence of activated, dendritic melanocytes was seen. CONCLUSIONS: Considering our results, and following further studies, RCM clinical applications could be used in the therapeutic monitoring and evaluation of the evolution of vitiligo. 相似文献
8.
9.
10.